Voyager Therapeutics (VYGR)
(Delayed Data from NSDQ)
$7.62 USD
+0.20 (2.70%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $7.62 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Earnings News For VYGR
-
Voyager Therapeutics: Q4 Earnings Snapshot
-
Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
-
Voyager Therapeutics: Q3 Earnings Snapshot
-
Voyager Therapeutics Reports Third Quarter 2023 Financial and Operating Results
-
Voyager Therapeutics (VYGR) Reports Q2 Loss, Tops Revenue Estimates
-
Voyager Therapeutics Reports Second Quarter 2023 Financial and Operating Results
-
Voyager Therapeutics (VYGR) Q1 Earnings and Revenues Surpass Estimates
-
Voyager Therapeutics: Q1 Earnings Snapshot
-
Voyager Therapeutics Reports First Quarter 2023 Financial and Operating Results
-
Voyager Therapeutics (VYGR) Reports Q4 Loss, Misses Revenue Estimates
-
Voyager Therapeutics: Q4 Earnings Snapshot
-
Voyager Therapeutics Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
-
Voyager Therapeutics (VYGR) Beats Q3 Earnings and Revenue Estimates
-
Voyager Therapeutics: Q3 Earnings Snapshot
-
Voyager Therapeutics Reports Third Quarter 2022 Financial and Operating Results
-
Voyager Therapeutics (VYGR) Expected to Beat Earnings Estimates: Should You Buy?
-
Voyager Therapeutics (VYGR) Reports Q2 Loss, Misses Revenue Estimates
-
Voyager Therapeutics: Q2 Earnings Snapshot
-
Voyager Therapeutics Prioritizes Pipeline and Reports Second Quarter 2022 Financial and Operating Results
-
Voyager Therapeutics (VYGR) Reports Q1 Loss, Misses Revenue Estimates
-
Will Voyager Therapeutics (VYGR) Report Negative Q4 Earnings? What You Should Know
-
Voyager Therapeutics (VYGR) Reports Q3 Loss, Lags Revenue Estimates
-
Earnings Preview: Voyager Therapeutics (VYGR) Q3 Earnings Expected to Decline
-
Voyager Therapeutics (VYGR) Reports Q2 Loss, Misses Revenue Estimates
-
Analysts Estimate Voyager Therapeutics (VYGR) to Report a Decline in Earnings: What to Look Out for